ZyVersa Therapeutics Bolsa (NASDAQ: ZVSA)

Últimas noticias sobre ZyVersa Therapeutics (NASDAQ:ZVSA) Bolsa

ZyVersa Therapeutics

ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.

ZyVersa Therapeutics, Inc. - Common Stock

ZyVersa Therapeutics Inc

The CNN Money Fear and Greed index showed an improvement in the overall market sentiment, while the index remained in the &#8220;Extreme Fear&#8221; zone on Friday.
U.S. stocks settled higher on Friday, with the S&amp;P 500 surging more than 2% during the session.
Big tech shares fell sharply last week and saw a sharp recovery on Friday. Shares of Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) jumped more than 5%, while Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) added around 4% during the session.
Despite Friday's gains, stocks recorded losses last week. The Dow dipped around 3.1% to record its worst week since March 2023. The S&amp;P 500 dipped over 2%, recording its fourth straight losing week.
On the economic data front, the University of Michigan consumer sentiment dipped to 57.9 in March, recording the lowest reading since November 2022, compared to 64.7 in the previous month and down from market estimates of 63.1.
All sectors on the S&amp;P 500 closed on a positive note, with information technology, energy, and financial stocks recording the biggest gains on Friday.
The Dow Jones closed higher by around 675 points to 41,488.19 on Friday. The S&amp;P 500 rose 2.13% to 5,638.94, while the Nasdaq Composite climbed 2.61% at 17,754.09 during Friday's session.
Investors are awaiting earnings results from Science Applications International Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIC#NASDAQ">SAIC</a>), Getty Images Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GETY#NYSE">GETY</a>) and Consolidated Water Co. Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CWCO#NASDAQ">CWCO</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 21, the index remained in the &#8220;Extreme Fear&#8221; zone on Friday, versus a prior reading of 16.1.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44326690/top-3-materials-stocks-that-may-collapse-in-march">Top 3 Materials Stocks That May Collapse In March</a></li>
</ul>
Photo courtesy: Shutterstock

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

CWCO

GETY

NVDA

SAIC

TSLA

S&P Jumps Over 2%, But Records Weekly Loss: Investor Fear Eases, Greed Index Remains In 'Extreme Fear' Zone

Business Outlook
As macro-economic uncertainties persist, the Company intends to maintain a prudent approach in its business planning for 2025. Management will continue to focus on enhancing efficiency of the Company's operations. As such, for the first quarter of 2025, the Company expects to generate a net income between RMB1.75 billion and RMB1.85 billion and a non-GAAP net income&#x2A;13 between RMB1.80 billion and RMB1.90 billion, representing a year-on-year growth between 49% and 58%. This outlook reflects the Company's current and preliminary views, which is subject to material changes.

Guidance

QFIN

Qifu Technology Q1 Outlook: Expects Net Income Of RMB1.75B–RMB1.85B And Non-GAAP Net Income Of RMB1.80B-RMB1.90B

Semi-Annual Dividend for the Second Half of 2024
The board of directors of the Company (the "Board") has approved a dividend of US$0.35 per Class A ordinary share, or US$0.70 per ADS for the second half of 2024 to holders of record of Class A ordinary shares and ADSs as of the close of business on April 23, 2025 Hong Kong Time and New York Time, respectively, in accordance with the Company's dividend policy. For holder of Class A ordinary shares, in order to qualify for the dividend, all valid documents for the transfers of shares accompanied by the relevant share certificates must be lodged for registration with the Company's Hong Kong branch share registrar, Computershare Hong Kong Investor Services Limited, at Shops 1712-1716, 17th Floor, Hopewell Centre, 183 Queen's Road East, Hong Kong no later than 4:30 p.m. on April 23, 2025 (Hong Kong Time). The payment date is expected to be on May 28, 2025 for holders of Class A ordinary shares and around June 2, 2025 for holders of ADSs

Dividends

Qifu Technology Raises Semi-Annual Dividend To $0.70 Per ADS From $0.60, Payable June 2; And $0.35 Per Class A Share Payable May 28

Qifu Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QFIN#NASDAQ">QFIN</a>) reported quarterly earnings of RMB13.66 per share which beat the analyst consensus estimate of RMB12.23 by 11.69 percent. This is a 91.32 percent increase over earnings of RMB7.14 per share from the same period last year. The company reported quarterly sales of RMB4.48 billion which beat the analyst consensus estimate of RMB4.25 billion by 5.53 percent. This is a 0.29 percent decrease over sales of RMB4.50 billion the same period last year.

Earnings Beats

Qifu Technology Q4 2024 Adj EPS RMB13.66 Beats RMB12.23 Estimate, Sales RMB4.48B Beat RMB4.25B Estimate

- Continued favorable safety profile for DYNE-251 -
- DELIVER Registrational Expansion Cohort is fully enrolled;&nbsp;data from this cohort planned for late 2025 -
- Potential for Biologics License Application submission for U.S. accelerated approval&nbsp;in early 2026 -

Reported Earlier, Dyne Therapeutics Phase 1/2 Trial Update Highlights Sustained Functional Improvement In Duchenne Muscular Dystrophy With Exon 51-Skipping Candidate; Regulatory Submission Targeted For Early 2026

The cryptocurrency market witnessed a significant rebound last week, ably supported by leading memecoins and Telegram-linked Toncoin.
What happened: BNX, the native token of the GameFi platform BinaryX, topped the gainers list, exploding over 60% over the week.
The BNB Chain (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/bnb/usd">BNB</a>)-based coin was just 10% away from bettering its all-time high set two years ago.&nbsp;
The rally came ahead of the project's rebranding to Four (FORM) to align with its newest product, Four.meme, an ecosystem for meme coins.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Four is evolving, and the future is <a href="https://twitter.com/search?q=%24FORM&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$FORM</a>. To bring clarity and truly return Four to the community, we are revising the token symbol from <a href="https://twitter.com/search?q=%24Four&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$Four</a> to <a href="https://twitter.com/search?q=%24FORM&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$FORM</a>.<a href="https://twitter.com/search?q=%24FORM&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$FORM</a> represents continuous creation and infinite possibilities. The ecosystem remains strong—we're building DeFi, GameFi,… <a href="https://t.co/OFWDdohOCl">pic.twitter.com/OFWDdohOCl</a>
&mdash; BinaryX (@binary_x) <a href="https://twitter.com/binary_x/status/1893927616861876319?ref_src=twsrc%5Etfw">February 24, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Toncoin, the native token of The Open Network, was the second most successful cryptocurrency over the week, returning over 34% to its holders.&nbsp;
The surge followed the <a href="https://in.benzinga.com/tech/25/03/44347961/ton-token-value-soars-20-as-telegram-founder-pavel-durov-regains-passport-from-french-authorities">recovery</a> of Telegram founder Pavel Durov‘s passport from French authorities. The tech entrepreneur was<a href="https://www.benzinga.com/news/24/09/40743743/telegram-founder-pavel-durov-slams-france-in-first-public-comments-since-detention-still-trying-to-u"> detained</a> in August 2024 amid an investigation into crimes related to child pornography, drug trafficking, and fraudulent transactions on the popular social messaging platform.
The decentralized exchange token CAKE followed with a 30% spike last week, aided by an 11% weekly <a href="https://defillama.com/dexs">increase </a>in volumes on PancakeSwap.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Gains +/-</td>
<td>Price (Recorded at 12:30 a.m. ET)</td>
</tr>
<tr>
<td>BinaryX (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">BNX</a>)</td>
<td>+60.71%</td>
<td>$1.62</td>
</tr>
<tr>
<td>Toncoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TON</a>)</td>
<td>+34.00%</td>
<td>$3.59</td>
</tr>
<tr>
<td>PancakeSwap (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/cake/usd">CAKE</a>)</td>
<td>+30.86%</td>
<td>$2.04</td>
</tr>
</tbody>
</table>
</figure>
See Also:<a href="https://www.benzinga.com/24/12/42735744/pharma-bro-martin-shkreli-predicts-doom-for-michael-saylors-microstrategy-as-stock-dips-below-300-in-after-hours-trading"> </a><a href="https://www.benzinga.com/25/03/44267582/us-house-committee-favors-stablecoin-regulation-to-strenthen-dollar-advocates-against-cbdc">House Committee Favors Stablecoin Regulation To &#8216;Strengthen&#8217; Dollar: Majority Whip Says CBDCs Against &#8216;American Values&#8217;</a>
Market leader Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) eked out a gain of 1.10%, while Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), the second-largest cryptocurrency, fell more than 8% in a week.
Meme heavyweight Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) was broadly unchanged over the previous week, while Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) and Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>) outperformed with gains of 8.50% and 10.87%, respectively.
The total cryptocurrency market capitalization rose 4.5% over the week to $2.71 trillion.
Photo by Avi Rozen on Shutterstock
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/03/44268317/sec-postpones-approval-of-several-crypto-spot-etfs-says-influential-analyst">Dogecoin, XRP ETF Filings Delayed By SEC But Influential Analyst Says &#8216;Relatively High&#8217; Odds Of Approval</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BNB

$BNX

$BTC

$CAKE

$DOGE

$ETH

$PEPE

$SHIB

$TON

Bitcoin, Dogecoin Were Muffled Last Week But Telegram's Pavel Durov Getting His Passport Back Gave Toncoin Its Wings

<ul>
<li>Primary endpoint showed clinically meaningful improvement in patients with SMA receiving apitegromab as measured by gold standard Hammersmith Functional Motor Scale Expanded (HFMSE) versus placebo (p=0.0192), with consistent outcomes across all major sub-groups including age, SMN-targeted background therapy, and age at initiation of SMN-targeted therapy</li>
<li>Pre-specified secondary endpoint showed that 30.4% of patients receiving apitegromab had ≥ 3-point improvement in HFMSE versus 12.5% of patients on placebo (nominal p-value = 0.0156), despite all study patients receiving ongoing SMN-targeted background therapy</li>
<li>In other pre-specified secondary endpoints, patients with SMA receiving apitegromab showed consistent improvement at 52 weeks compared to placebo as measured by Revised Upper Limb Module (RULM) and WHO motor development milestones despite all study patients receiving ongoing SMN-targeted background therapy</li>
</ul>

SRRK

Reported Earlier, Scholar Rock's New Phase 3 Trial Data Show Clinically Meaningful Improvements In Motor Function For Patients With SMA

Each unit consists of one share of common stock and one warrant to purchase one share of common stock. The warrants will be immediately exercisable at $1.08 per share and will expire 60 days from the date of issuance.&nbsp;

Reported Earlier, Castellum Prices $4.5M Public Offering Of 4.5M Units At $1.00 Per Unit

Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) continues to trade at elevated valuation levels despite Warren Buffett&#8216;s Berkshire Hathaway Inc. significantly reducing its stake in the iPhone maker, according to a prominent market analyst.
What Happened: Lawrence McDonald, founder of Bear Traps Report, highlighted concerns about Apple&#8217;s current price-to-sales ratio in a post on X on Sunday. 
&#8220;Think about your 401k and Apple, its (S&amp;P 500) Top holding — From 2005 to 2020, Apple traded between a 2 and 5 handle price to sales. On Christmas Eve, she peaked at 10.2x sales and now sits—After Buffett dumped nearly 70% of his shares—at 8.2x,&#8221; McDonald wrote.
The price-to-sales ratio measures a company&#8217;s market cap relative to revenue, showing how much investors pay per dollar of sales. Apple&#8217;s current 8.2x P/S far exceeds its historical 2-5x range, a premium it began surpassing after June 2020, according <a href="https://companiesmarketcap.com/inr/apple/ps-ratio/">to</a> CompaniesMarketCap
McDonald warned that the growing influence of passive index funds is damaging the market&#8217;s ability to price stocks efficiently, with Apple being a prime example.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Think about your 401k and Apple, its (S&amp;P 500) TOP holding — From 2005 to 2020, <a href="https://twitter.com/search?q=%24AAPL&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$AAPL</a> traded between a 2 and 5 handle price to sales. On Christmas Eve, she peaked at 10.2x sales and now sits—AFTER Buffett dumped nearly 70% of his shares—at 8.2x. The larger passive index funds… <a href="https://t.co/d2hVBNsWlr">https://t.co/d2hVBNsWlr</a> <a href="https://t.co/uY7Syrgudj">pic.twitter.com/uY7Syrgudj</a>
&mdash; Lawrence McDonald (@Convertbond) <a href="https://twitter.com/Convertbond/status/1901258281739268133?ref_src=twsrc%5Etfw">March 16, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/markets/equities/25/03/44349240/googles-waymo-leads-robotaxi-race-with-2-millon-paid-rides-zoox-challenges-tesla-for-second-spot-as-unsupervised-autonomy-becomes-table-stakes-says-gary-black">Google&#8217;s Waymo Leads Robotaxi Race With 2 Millon Paid Rides, Amazon&#8217;s Zoox Challenges Tesla For Second Spot As Autonomy Becomes &#8216;Table Stakes,&#8217; Says Gary Black</a>
Why It Matters: The comments come after Buffett&#8217;s dramatic reduction in Berkshire&#8217;s Apple holdings over the past year. Berkshire held 905.6 million Apple shares valued at approximately $174 billion at the start of 2024 but sold 116.2 million shares in the first quarter and an additional 389.7 million in the second quarter. 
By the end of the third quarter, Buffett had further reduced the position to <a href="https://www.benzinga.com/markets/equities/24/10/41428505/warren-buffett-may-have-missed-out-on-23m-worth-of-profits-after-selling-apple-stocks-report">around 300 million shares</a>.
The valuation concerns and China sales troubles have impacted Apple&#8217;s stock performance. While AAPL gained 14.8% over the past year, it significantly underperformed the S&amp;P 500&#8217;s 25.6% rise <a href="https://www.benzinga.com/tech/25/01/43198776/will-warren-buffett-sell-more-apple-stock-after-iphone-sales-drop-in-china">during the same period</a>. 
A recent <a href="https://www.benzinga.com/tech/25/01/43198776/will-warren-buffett-sell-more-apple-stock-after-iphone-sales-drop-in-china">investor poll by Benzinga</a> showed opinion nearly evenly split on Buffett&#8217;s next move, with 56% believing he will maintain his remaining Apple position for the long term, while 44% expect further reductions soon.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/03/44349451/third-largest-buy-the-dip-in-history-bofas-sees-correction-not-a-bear-market-amid-wall-street-rebound">Third-Largest &#8216;Buy-The-Dip&#8217; In History — BofA&#8217;s Sees &#8216;Correction, Not A Bear Market&#8217; Amid Wall Street Rebound</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

AAPL

Warren Buffett Dumped Nearly 70% Of Apple Shares, But Its Price-To-Sales Ratio Remains Elevated At 8.2x, Warns This Market Analyst

Once a <a href="https://www.benzinga.com/government/24/01/36719920/roomba-maker-irobot-struggles-with-potential-eu-rejection-of-amazon-acquisition-and-falling-sales-an">potential acquisition target</a> for Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), iRobot Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRBT#NASDAQ">IRBT</a>) — the maker of Roomba — is now playing catch-up to hold its ground against Chinese competitors.
What Happened: iRobot, the company behind the iconic Roomba vacuum, is facing mounting pressure from Chinese tech manufacturers such as Roborock, Ecovacs, Xiaomi Corporation (OTC:<a class="ticker" href="https://www.benzinga.com/stock/XIACY#OTC">XIACY</a>), and Dreame Technology, <a href="https://asia.nikkei.com/Business/China-tech/Chinese-robot-vacuums-leave-Roomba-in-the-dust-with-arms-and-legs">reported</a> Nikkei Asia.
Once considered the undisputed leader in the robot vacuum market, iRobot's global market share has dropped from 35% in 2015 to just 22% in 2023, according to Euromonitor.
See Also:&nbsp;<a href="https://www.benzinga.com/tech/25/03/44069535/jeff-bezos-backed-anthropic-pushes-for-stronger-us-ai-safeguards-saying-autocracies-like-china-russia-could-use-ai-to-expand-their-power-some-very-dark-possbilities" target="_blank" rel="noreferrer noopener">Jeff Bezos-Backed Anthropic Pushes For Stronger US AI Safeguards, Saying Autocracies Like China, Russia Could Use AI To Expand Their Power: ‘Some Very Dark Possibilities'</a>
Beijing-based Roborock unveiled a new robot vacuum at CES 2025 featuring an AI-powered arm capable of picking up objects weighing up to 300 grams. The vacuum can recognize 108 objects out of the box, with room to program 50 more via app.
In Japan, where Roomba holds a 70% market share, Chinese rivals are rapidly gaining ground. Ecovacs is undercutting Roomba by nearly 30% with comparable features, while Xiaomi is preparing to launch robot vacuums in its new retail stores.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It's Important: On Wednesday, it reported a 44% year-over-year <a href="https://in.benzinga.com/25/03/44274332/why-consumer-robot-maker-irobots-stocks-are-plunging-today">drop in fourth-quarter sales</a>, totaling $172.03 million, surpassing the analyst consensus forecast of $171.00 million.
The company revealed significant uncertainty about its ability to sustain operations for at least 12 months following the release of its consolidated 2024 financial statements.
Due to these circumstances, it has canceled the fourth-quarter earnings call that was set for March 12, 2025, and is refraining from issuing a financial outlook for 2025 at this time.
Price Action: IRBT shares surged 21.11% on Friday, closing at $3.70. However, they dipped 0.27% in after-hours trading at the time of writing. Year-to-date, the stock has declined 53.46%, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Photo Courtesy: DestinaDesign on Shutterstock.com
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://in.benzinga.com/25/02/43589437/bill-gates-on-musk-and-bezos-space-obsession-im-not-a-big-mars-person-its-not-a-very-hospitable-place" target="_blank" rel="noreferrer noopener">Bill Gates Would Rather Save Earth Than Colonize Mars — Unlike Elon Musk, Jeff Bezos: ‘I'm Not a Big Mars Person… It's Not a Very Hospitable Place'</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

Tech

Media

AMZN

IRBT

XIACY

Amazon Pursued Roomba's Parent Once, But Now The Company's Robot Vacuums Face Heat From Chinese Rivals With AI-Powered Arms

Macro Economic Events

Econ #s

Economics

Reported Earlier, Chinese Unemployment Rate For February 5.4% Vs. 5.1% Est.; 5.1% Prior

Reported Earlier, China Industrial Production Year to Date (YoY) For February 5.9% Vs. 5.8% Prior

Reported Earlier, China Industrial Production (YoY) For February 5.9% Vs. 5.3% Est.; 6.2% Prior

Reported Earlier, China Fixed Asset Investment (YoY) For February 4.1% Vs. 3.2% Est.; 3.2% Prior

Harrow, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HROW#NASDAQ">HROW</a>) will release its fourth-quarter financial results, after the closing bell, on <a href="https://www.benzinga.com/quote/HROW/earnings">Monday, March 17</a>.
Analysts expect the Nashville, Tennessee-based company to report a quarterly loss at 1 cent per share, versus a year-ago loss of 2 cents per share. Harrow projects quarterly revenue of $58.41 million, compared to $36.35 million a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On March 11, Harrow announced the execution of a five-year strategic supply and development agreement for TRIESENCE&#xAE;.
Harrow shares gained 3.5% to close at $23.01 on Friday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/HROW/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>HC Wainwright &amp; Co. analyst Yi Chen initiated coverage on the stock with a Buy rating and a price target of $57 on Feb. 6, 2025. This analyst has an accuracy rate of 60%.</li>
<li>B. Riley Securities analyst Mayank Mamtani reiterated a Buy rating with a price target of $50 on Aug. 29, 2024. This analyst has an accuracy rate of 72%.</li>
</ul>
Considering buying HROW stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="601" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/16043905/image-130-1024x601.png" alt="" class="wp-image-826054" style="width:344px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/16043905/image-130-1024x601.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/16043905/image-130-300x176.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/16043905/image-130-768x450.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/16043905/image-130.png 1103w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44326690/top-3-materials-stocks-that-may-collapse-in-march">Top 3 Materials Stocks That May Collapse In March</a></li>
</ul>

Price Target

Analyst Ratings

HROW

Harrow Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

North Korea, helped by the infamous hacking syndicate Lazarus Group, has quietly become one of the biggest holders of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>).
What Happened: The attacker possessed around 13,518 BTCs as of this writing, worth $1.16 billion, <a href="https://intel.arkm.com/explorer/entity/lazarus-group">according </a>to on-chain analytics platform Arkham. The stash was worth more than twice the amount held by <a href="https://www.benzinga.com/25/03/44133314/el-salvadors-president-bukele-remains-defiant-amid-imfs-concerns-on-bitcoin-accumulation-it-wont-stop-now-and-it-wont-stop-in-the-future">El Salvador</a>, the widely known Bitcoin-friendly nation.
Lazarus Group&#8217;s BTC stockpile has soared dramatically since its massive $1.4 billion Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) <a href="https://in.benzinga.com/markets/cryptocurrency/25/02/43901287/north-koreas-lazarus-group-suspected-in-1-4-billion-bybit-crypto-hack">hack </a>on the cryptocurrency exchange&nbsp;Bybit. 
Before Feb. 22, the syndicate owned 778 BTCs, which surged to approximately 14,000 by Mar. 4, suggesting that it laundered stolen funds into Bitcoin.
See Also:<a href="https://www.benzinga.com/24/12/42735744/pharma-bro-martin-shkreli-predicts-doom-for-michael-saylors-microstrategy-as-stock-dips-below-300-in-after-hours-trading"> </a><a href="https://www.benzinga.com/25/03/44267582/us-house-committee-favors-stablecoin-regulation-to-strenthen-dollar-advocates-against-cbdc">House Committee Favors Stablecoin Regulation To &#8216;Strengthen&#8217; Dollar: Majority Whip Says CBDCs Against &#8216;American Values&#8217;</a>
Why It Matters: The Lazarus Group, a collective of&nbsp;North Korean state-sponsored crypto hackers,&nbsp;is considered one&nbsp;of the most sophisticated on-chain&nbsp;operators globally.
U.S.-based agencies, such as the Federal Bureau of Investigation have <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40725296/kim-jong-uns-north-korea-backed-hackers-may-target-bitcoin-and-ethereum-etfs-fbi-issues-wa">raised alarms</a> about the infiltration tactics employed by North Korean hackers to steal blue-chip cryptocurrencies such as Bitcoin and Ethereum.
The U.S. government&nbsp;has also <a href="https://home.treasury.gov/news/press-releases/sm774" target="_blank" rel="noreferrer noopener">claimed</a>&nbsp;that the illegal proceeds from the thefts are used to fund North Korea&#8217;s weapons and missile program.
Price Action: At the time of writing, Bitcoin was exchanging hands at $83,644.48, down 0.75% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.
Image via Shutterstock
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/03/44268317/sec-postpones-approval-of-several-crypto-spot-etfs-says-influential-analyst">Dogecoin, XRP ETF Filings Delayed By SEC But Influential Analyst Says &#8216;Relatively High&#8217; Odds Of Approval</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" rel="noreferrer noopener" target="_blank"></a>

Kim Jong Un's North Korea-Backed Lazarus Group Now Has More Bitcoin Than El Salvador

As the AI race intensifies, Baidu, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) has positioned itself as a serious contender by launching two new models it says rival top competitors.
What Happened: On Sunday, Baidu unveiled ERNIE X1 and ERNIE 4.5, the latest iterations of its artificial intelligence models designed to compete in a landscape dominated by players like OpenAI and DeepSeek, reported Reuters.
"ERNIE X1 delivers performance on <a href="https://in.benzinga.com/government/regulations/25/03/44201104/usa-targets-deepseek-weighs-restrictions-on-chinas-ai-firm-that-shook-nvidias-market-value-by-600-billion">par with DeepSeek R1</a> at only half the price," Baidu said in a statement, describing it as a "reasoning-focused" model with superior capabilities in understanding, planning, reflection, and evolution.
The company also said that it's the first "deep thinking" model to use tools autonomously.
See Also: <a href="https://www.benzinga.com/news/legal/25/03/44344993/apple-reportedly-fights-uk-governments-unacceptable-encryption-order-behind-closed-doors-no-press-or-public-allowed">Apple Reportedly Fights UK Government&#8217;s &#8216;Unacceptable&#8217; Encryption Order Behind Closed Doors — No Press Or Public Allowed</a>
ERNIE 4.5 reportedly features "excellent multimodal understanding ability," meaning it can process and generate across text, image, audio, and video formats.
Baidu said its language, memory, logic, and content-generation skills are all "comprehensively improved."
The company also touted its model's emotional intelligence: "It has high EQ. It can understand memes and satirical cartoons," Baidu added.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It&#8217;s Important: The new models come at a time when <a href="https://in.benzinga.com/25/03/44254562/deepseek-stays-free-founder-rejects-monetization-plans-new-reasoning-model-amid-alibaba-talks">DeepSeek has disrupted</a> the global AI race by releasing high-performance models at significantly lower costs than U.S. rivals.
Although Baidu was one of China's first tech giants to launch a ChatGPT-style chatbot, widespread adoption has been elusive, the report noted.
Last month, Baidu&#8217;s market value <a href="https://in.benzinga.com/25/02/43765049/baidus-market-value-plummets-by-24-billion-following-ceos-absence-from-crucial-meeting-led-by-chinese-president-xi">dropped by $2.4 billion</a> following the absence of its founder, Robin Li, from a significant meeting with Chinese President Xi Jinping.
Baidu&#8217;s Q4 earnings report revealed a <a href="https://in.benzinga.com/news/earnings/25/02/43778265/baidu-q4-earnings-ai-cloud-grows-margin-slides-expects-ai-investments-to-bear-fruit-in-2025">2% decline in revenue</a> year-on-year, although it surpassed analyst expectations.
Check out more of Benzinga&#8217;s Consumer Tech coverage by <a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Photo by testing on Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/24/12/42739523/apple-amazon-samsung-and-nintendo-what-tech-marvels-are-these-giants-cooking-in-2025?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Apple, Amazon, Samsung, And Nintendo: What Tech Marvels Are These Giants Cooking In 2025</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

BIDU

Baidu Says Its New AI Is Smarter Than DeepSeek's — And Costs Half As Much: 'Excellent Multimodal Understanding Ability'

Official Melania (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">MELANIA</a>) dramatically spiked on Sunday after a whale opened a five-fold leveraged long position in the meme coin.
What happened: The official cryptocurrency of First Lady Melania Trump jumped 6.29% over the previous day, while its trading volume more than tripled to $35 million. The cryptocurrency outperformed Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), and Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) in the last 24 hours.
The price skyrocketed after an influential trader, who made news for taking a 40x <a href="https://in.benzinga.com/markets/cryptocurrency/25/03/44348215/bitcoin-whale-takes-332-million-short-position-heres-where-it-gets-liquidated">leveraged short position</a> on Bitcoin, opened a 5x leveraged trade betting on MELANIA&#8217;s price increase.
The position, worth $2.5 million at the time of writing, was opened at an entry price of $0.69135, <a href="https://hypurrscan.io/address/0xf3F496C9486BE5924a93D67e98298733Bb47057c">according </a>to data from the decentralized perpetual trading platform Hyperliquid.&nbsp;
Since opening the long, the trader has made an unrealized profit of over $105,000.
Benzinga Note: Leverage trading allows cryptocurrency traders to open larger positions using borrowed capital. While it can potentially amplify profits, it also significantly increases the risk of substantial losses due to the volatile nature of the cryptocurrencies.
See Also:<a href="https://www.benzinga.com/24/12/42735744/pharma-bro-martin-shkreli-predicts-doom-for-michael-saylors-microstrategy-as-stock-dips-below-300-in-after-hours-trading"> </a><a href="https://www.benzinga.com/25/03/44267582/us-house-committee-favors-stablecoin-regulation-to-strenthen-dollar-advocates-against-cbdc">House Committee Favors Stablecoin Regulation To &#8216;Strengthen&#8217; Dollar: Majority Whip Says CBDCs Against &#8216;American Values&#8217;</a>
Why It Matters: The high-stakes bet revived interest for a coin that has collapsed since its initial frenzy.&nbsp;
MELANIA has plunged nearly 95% from the all-time high of $13.73 set shortly after its <a href="https://in.benzinga.com/markets/cryptocurrency/25/01/43078040/trump-coin-tanks-36-even-as-melania-trump-launches-her-own-token-top-analyst-says-his-short-is-going-very-very-well">January launch.</a> Additionally, the downturn has wiped off $13 billion worth of the coin&#8217;s fully diluted capitalization, which was now valued at $724 million.
Price Action: At the time of writing, MELANIA was exchanging hands at $0.7246, up 6.23% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>. 
Photo Courtesy: Evan El-Amin On Shutterstock.com
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/03/44268317/sec-postpones-approval-of-several-crypto-spot-etfs-says-influential-analyst">Dogecoin, XRP ETF Filings Delayed By SEC But Influential Analyst Says &#8216;Relatively High&#8217; Odds Of Approval</a></li>
</ul>

Movers

$MELANIA

MELANIA Surges 6% After Whale With 40x Short Bet On Bitcoin Goes Long On First Lady's Memecoin

Popular dog-themed cryptocurrency Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) traded higher on Sunday, defying the broader meme coin correction.&nbsp;
What happened: The second-largest meme coin by market capitalization jumped 5.45% over the previous day, with trading volume surging 189% to $341 million in the last 24 hours.&nbsp;
In doing so, SHIB became the most successful large-cap meme coin in the last 24 hours, outperforming Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) and several others that recorded losses.
The rally followed a <a href="https://in.benzinga.com/markets/cryptocurrency/25/03/44348135/shiba-inus-burn-rate-soars-removing-505-million-tokens-from-circulation">massive 62,000% jump</a> in the token's burn rate, boosted by a meteoric jump in transactions on the ecosystem's Layer-2 blockchain Shibarium.
Note that a portion of transaction fees paid on Shibarium are set aside and burned. This is done to create scarcity and, over time, increase the token&#8217;s market value.
See Also:<a href="https://www.benzinga.com/24/12/42735744/pharma-bro-martin-shkreli-predicts-doom-for-michael-saylors-microstrategy-as-stock-dips-below-300-in-after-hours-trading"> </a><a href="https://www.benzinga.com/25/03/44267582/us-house-committee-favors-stablecoin-regulation-to-strenthen-dollar-advocates-against-cbdc">House Committee Favors Stablecoin Regulation To &#8216;Strengthen&#8217; Dollar: Majority Whip Says CBDCs Against &#8216;American Values&#8217;</a>
Why It Matters: Widely followed cryptocurrency analyst Javon Marks maintained a $0.000081 price target for SHIB, which represented a 500% upside over the current price.
"As prices continue to hold broken out, and up since showing responsiveness to this breakout, another nearly +500% upside to reach this target could still be well in the works," the analyst added.&nbsp;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24SHIB&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$SHIB</a> (Shiba Inu)&#39;s breakout target at the $0.000081 level goes UNCHANGED! As prices continue to hold broken out, and up since showing responsiveness to this breakout, another nearly +500% upside to reach this target could still be well in the works&#8230; <a href="https://t.co/HpENwKPFfb">https://t.co/HpENwKPFfb</a> <a href="https://t.co/kNJx4aq8if">pic.twitter.com/kNJx4aq8if</a>
&mdash; JAVON&#x26a1;&#xFE0F;MARKS (@JavonTM1) <a href="https://twitter.com/JavonTM1/status/1901306023106806056?ref_src=twsrc%5Etfw">March 16, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The Momentum indicator, which compares the short-term price and long-term price, flashed a &#8220;Buy&#8221; signal for SHIB as of this writing, <a href="https://in.tradingview.com/symbols/SHIBUSDT/technicals/">according </a>to TradingView.&nbsp;
Conversely, the Bull Bear Power indicator, which measures the strength of buyers and sellers, signaled "Sell," indicating that the rally might not be sustained for long.
Price Action: At the time of writing, SHIB was exchanging hands at $0.00001351, up 5.79% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.
Image via Shutterstock
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/03/44268317/sec-postpones-approval-of-several-crypto-spot-etfs-says-influential-analyst">Dogecoin, XRP ETF Filings Delayed By SEC But Influential Analyst Says &#8216;Relatively High&#8217; Odds Of Approval</a></li>
</ul>

Shiba Inu Defies Memecoin Dump With With A 5% Spike — Analyst Says 500% Upside 'Could Still Be Well In The Works'

Young Liu, the CEO of Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) supplier Foxconn, also known as Hon Hai Technology, has publicly criticized President Donald Trump's tariff policy, warning it's creating chaos for tech giants like Apple and Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>).
What Happened: During an earnings call on Friday, Foxconn CEO Liu said the U.S. government&#8217;s tariff strategy is causing major disruptions across the global tech supply chain.
"The issue of tariffs is something that is giving the CEOs of our customers a big headache now," Liu told investors. "Judging by the attitude and the approach we see the U.S. government taking towards tariffs, it is very, very hard to predict how things will develop over the next year."
Liu said that companies, including Apple and Amazon, are actively exploring U.S.-based manufacturing options with Foxconn. While he declined to disclose details, Liu stated that the company expects "more and more" production to move stateside.
See Also: <a href="https://www.benzinga.com/news/24/03/37848556/nvidias-new-superchip-delivers-8-470-times-the-computing-performance-of-supercomputer-that-jensen-hu" target="_blank" rel="noreferrer noopener">Nvidia&#8217;s New Superchip Delivers 8,470 Times The Computing Performance Of Supercomputer That Jensen Huang Donated To OpenAI</a>
The news was first <a href="https://www.ft.com/content/cc290f55-e45a-42b1-bf2d-cf323053fade">reported</a> by the Financial Times.
Why It's Important: Foxconn's manufacturing operations are heavily concentrated in China, India, and Vietnam — all of which have been impacted or are at risk of being hit by additional tariffs.
The company is also building a major Nvidia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) server plant in Mexico.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
On Friday, Foxconn announced its financial results for the fourth quarter and full year of 2024. In the October-December quarter, Foxconn&#8217;s revenue surged 15% year-over-year to NT$2.13 trillion, while gross profit climbed 15.7% to NT$131 billion. For the full year, net profit totaled NT$152.7 billion, pushing earnings per share to NT$11.01—the highest in 17 years.
The concerns raised by Liu echo broader criticisms of the U.S. tariff policy. Previously, in an interview, Warren Buffett described tariffs <a href="https://in.benzinga.com/markets/equities/25/03/44070257/warren-buffett-calls-tariffs-an-act-of-war-warns-they-function-as-a-tax-on-goods-amid-market-turmoil">as &#8220;an act of war&#8221; and</a> likened them to a consumer tax.
Similarly, Anthony Scaramucci criticized the tariffs, stating that the <a href="https://in.benzinga.com/news/25/02/44032329/anthony-scaramucci-says-the-market-doesnt-like-trump-tariffs-compares-trump-to-hitler-appeaser-for-coddling-putin-and-berating-allies">market disapproves</a> of Trump&#8217;s trade policies.
Image via Shutterstock
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/personal-finance/25/03/44065932/mark-cuban-was-asked-how-hed-invest-100k-his-answer-buy-bulk-toothpaste-and-soup-for-the-best-guaranteed-return-on-investment" target="_blank" rel="noreferrer noopener">Mark Cuban Was Asked How He&#8217;d Invest $100K — His Answer? Buy Bulk Toothpaste And Soup For The ‘Best Guaranteed Return On Investment&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Trump Trade Policy A 'Big Headache' For Customers, Says Apple-Supplier Foxconn's CEO: 'Very, Very Hard To Predict How Things Will Develop...'

Press Releases

ZyVersa Therapeutics Highlights Published Data Demonstrating That Obesity Results in Neuroinflammation Implicated in Development of Neurodegenerative Diseases

Health Care

ZyVersa Therapeutics Highlights Review Article Supporting the Need for Drug Therapies to Treat the Inflammation of Obesity in Addition to Weight Loss Drugs

ZyVersa Therapeutics Highlights Published Data Demonstrating the Potential of Inflammasome Inhibition to Protect Pancreatic Islet Beta Cells and Attenuate Progression from Obesity to Insulin Resistance and Type 2 Diabetes

"Trump Media (NASDAQ: DJT) Surges on Election Day as SmallCap Stocks CRDL, ALBT, ZVSA, PRSO Emerge"

ZyVersa Therapeutics Reports Third Quarter, 2024 Financial Results and Provides Business Update

ZyVersa Therapeutics Announces Peer-Reviewed Publication Demonstrating That Inflammasome ASC Inhibitor IC 100 Protects Against Stroke-Related Cardiovascular Injury and Dysfunction in Preclinical Trial

ZyVersa Therapeutics' CEO, Stephen C. Glover, to Attend JPM's Healthcare Conference 2025 in San Francisco

ZyVersa Therapeutics Highlights Data Demonstrating NLRP3 Inflammasome Inhibition Reduces Inflammation, Improves Heart Function, and Restores Glucose Homeostasis and Insulin Sensitivity in Obese Animal Model of Heart Failure (HFpEF) and Type 2 Diabetes

Contracts

ZyVersa Therapeutics, Inc. Announces Pricing of $2.0 Million Private Placement Priced At The Market

ZyVersa Therapeutics Highlights Data Demonstrating Inflammasome Inhibition Reduces Neuroinflammation and Pathological Brain Deposition of Amyloid Beta in Alzheimer's Disease Mouse Model

ALBT

CRDL

PRSO

ZVSA

Aditxt

AEON Biopharma, Inc. Class A Common Stock

AEON Biopharma

Apollomics

AquaBounty Technologies, Inc. - Common Stock

AquaBounty Techs

Bone Biologics

Biodexa Pharmaceuticals plc - American Depositary Shares

Biodexa Pharmaceuticals

Capstone Holding

Entero Therapeutics

Pasithea Therapeutics Corp. - Common Stock

Pasithea Therapeutics

Lipella Pharmaceuticals Inc. - Common Stock

Lipella Pharmaceuticals

Matinas Biopharma Holdings, Inc. Common Stock

Matinas BioPharma Hldgs

NuCana

Onconetix

Palisade Bio

Protagenic Therapeutics, Inc. - Common Stock

Protagenic Therapeutics

Qualigen Therapeutics, Inc. - Common Stock

Qualigen Therapeutics

Quoin Pharmaceuticals, Ltd. - American Depositary Shares

Quoin Pharmaceuticals

TransCode Therapeutics, Inc. - Common Stock

TransCode Therapeutics

Scorpius Holdings

Shuttle Pharmaceuticals Holdings, Inc. - common stock

Shuttle Pharmaceuticals

Salarius Pharmaceuticals, Inc. - Common Stock

Salarius Pharmaceuticals

Syros Pharmaceuticals, Inc. - Common Stock

Syros Pharmaceuticals

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

Vincerx Pharma

Windtree Therapeutics, Inc. - Common Stock

Comments

ZyVersa Therapeutics

Noticias

Últimas noticias sobre ZyVersa Therapeutics (NASDAQ:ZVSA) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL